News
The Italian had a breakout season in the Serie A last term, with Liverpool and Inter Milan among those interested. However, ...
Neurocrine Biosciences has presented new one-year data from its Phase III CAHtalyst Adult study of Crenessity (crinecerfont) ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
HealthDay News — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...
The menopause transition offers a valuable opportunity to forecast a woman’s health risks, but clinicians should also prepare ...
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx ...
Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...
Rural, older, Black, and female Americans bear the brunt of the surge in obesity-related cancer mortality, new data show.
The 48th annual Mayor’s Cup Regatta and Festival drew crowds at both the City Beach and City Marina at the end of Dock Street. “There is just so much going on today. Sunrise Rotary really outdid ...
The new joint clinical practice guidelines from two endocrine societies make conditional recommendations for preconception, ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...
Obesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results